Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

On September 3, OBX-115, a novel TIL therapy, was granted FDA regenerative medicine advanced therapy (RMAT) designation in ...

Eli Lilly will invest $4.5 billion to create the Lilly Medicine Foundry, which the drug giant says will be the first-ever ...

ALT5 Sigma Corporation (NASDAQ:ALTS) (”ALT5” or the “Company”), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, ...

Researchers at the RIKEN Cluster for Pioneering Research (CPR) have developed technology that can alter, within the body, the ...

Ward County will continue to pursue a grant for a program to address opioid use disorder among jail inmates, despite one ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic ...

The new drug, Bristol Myers Squibb’s Cobenfy ... In November, the FDA agreed to review Karuna’s application. The next month, ...

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...